About Molecular Cytogenetics
Molecular cytogenetics is the combination of molecular biology and cytogenetics. It increases the resolution and diagnostic utility of cytogenetic analysis. FISH, which is molecular cytogenetic technique, is used for the identification of genetic disorders and the detection of chromosomal genetic abnormalities. CGH, which is also a molecular cytogenetic technique, is used to analyze the variations in copy numbers of the test sample by comparing it with the normal reference sample without using any cell culture.
Technavio’s analysts forecast the global molecular cytogenetics market to grow at a CAGR of 10.94% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global molecular cytogenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of molecular cytogenetics products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Molecular Cytogenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Agilent Technologies
• Bio-Rad Laboratories
• Thermo Fisher Scientific
Other prominent vendors
• Applied Spectral Imaging
• Biological Industries
• CytoTest
• Cytognomix
• F. Hoffmann-La Roche
• Illumina
• Leica Biosystems
• MetaSystems
• Oxford Gene Technology
• PerkinElmer
• SciGene
Market driver
• Growing aging population and increasing prevalence of chronic diseases
• For a full, detailed list, view our report
Market challenge
• Advent of alternative techniques
• For a full, detailed list, view our report
Market trend
• Increased focus on targeted cancer treatment
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Overview
• Market size and forecast
• Five forces analysis
PART 05: Segmentation by end-users
• Overview
• Clinical and research laboratories
• Pharmaceutical and biotechnology companies
• Others
PART 06: Segmentation by geography
• Overview
• Americas
• EMEA
• APAC
PART 07: Decision framework
PART 08: Drivers and challenges
• Market drivers
• Market challenges
PART 09: Market trends
• Increased focus on targeted cancer treatment
• Rising demand in emerging markets
• Transition from FISH to array-based technique
PART 10: Vendor landscape
• Competitive scenario
• Investment opportunity
PART 11: Key vendor analysis
• Abbott Laboratories
• Agilent Technologies
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Other prominent vendors
PART 12: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Molecular cytogenetics: Applications
Exhibit 02: Global molecular cytogenetics market: Overview 2016-2021
Exhibit 03: Global molecular cytogenetics market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global molecular cytogenetics market: Segmentation by end-users 2016-2021 (% share)
Exhibit 06: Global molecular cytogenetics market: Overview of segmentation by end-users
Exhibit 07: Global molecular cytogenetics market by clinical and research laboratories 2016-2021 ($ millions)
Exhibit 08: Global molecular cytogenetics market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 09: Global molecular cytogenetics market by others 2016-2021 ($ millions)
Exhibit 10: Number of hospitals in various countries 2014
Exhibit 11: Global molecular cytogenetics market: Segmentation by geography 2016-2021 (% share)
Exhibit 12: Global molecular cytogenetics market: Overview of segmentation by geography
Exhibit 13: Molecular cytogenetics market in Americas 2016-2021 ($ millions)
Exhibit 14: Prevalence of cancer in US 2015 (millions)
Exhibit 15: Molecular cytogenetics market in EMEA 2016-2021 ($ millions)
Exhibit 16: Molecular cytogenetics market in APAC 2016-2021 ($ millions)
Exhibit 17: Estimated investments in R&D by India and China 2010-2030
Exhibit 18: Preventive screening and diagnosis: Essential elements
Exhibit 19: Advantages of FISH over conventional methods
Exhibit 20: FISH and DMI: Comparison
Exhibit 21: Investments in R&D in APAC and GDP contribution 2016
Exhibit 22: FISH, CGH, and array CGH: Comparative analysis
Exhibit 23: Global molecular cytogenetics market: Investment potential
Exhibit 24: Abbott Laboratories: Overview
Exhibit 25: Abbott Laboratories: Strength analysis
Exhibit 26: Abbott Laboratories: Strategy assessment
Exhibit 27: Abbott Laboratories: Opportunity assessment
Exhibit 28: Agilent Technologies: Overview
Exhibit 29: Agilent Technologies: Strength analysis
Exhibit 30: Agilent Technologies: Strategy assessment
Exhibit 31: Agilent Technologies: Opportunity assessment
Exhibit 32: Bio-Rad Laboratories: Overview
Exhibit 33: Bio-Rad Laboratories: Strength analysis
Exhibit 34: Bio-Rad Laboratories: Strategy assessment
Exhibit 35: Bio-Rad Laboratories: Opportunity assessment
Exhibit 36: Thermo Fisher Scientific: Overview
Exhibit 37: Thermo Fisher Scientific: Strength analysis
Exhibit 38: Thermo Fisher Scientific: Strategy assessment
Exhibit 39: Thermo Fisher Scientific: Opportunity assessment
